Heart failure is one of the most common cardiovascular disorders in westem countries. Because (congestive) heart failure is a chronic, incapacitating disease with a poor prognosis and a substantial public health impact, the attention paid to this disorder in research and both scientific as well as popular publications is fully justified. In addition, the incidence and prevalence of heart failure tend to increase, in particular because of ageing of the population and increased survival after acute myocardial infarction.

, , , ,
D.E. Grobbee (Diederick)
Erasmus University Rotterdam
Netherlands Ministry of Health, NWO, Netherlands Heart Foundation, Dutch trombose Foundation, Rotterdam Medical Research Foundation, Topcon Europe BV,Rotterdamse Vereniging voorr Blindenbelangen, Stichting Bevordering voor Volkskracht, Stichting Fondsenwerving Acties Volksgezondheid, EMC Rotterdam, Utrecht Medical Center, AstraZeneca BV, Christiaens BV, Searle, Yamanouchi Pharma BV
Erasmus MC: University Medical Center Rotterdam

Feenstra, J. (2000, September 13). Adverse cardiovascular effects of drugs in patients with heart failure: Pharmaco-epidemioiogicai studies on ibopamine and NSAIDs. Erasmus University Rotterdam. Retrieved from http://hdl.handle.net/1765/20460